menu
    • menu

    Company profile for Lytix Biopharma

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Based in Oslo, Norway, Lytix Biopharma is a clinical stage biotech company developing novel cancer immunotherapies, an area within cancer therapy that is aimed at activating the patient’s immune system to fight cancer. The Company’s technology is based on pioneering research in “host defense peptides” – nature’s first line of defense towards foreign pathogens. Lytix Biopharma’s lead product, LTX-315, is a first-i...
    Based in Oslo, Norway, Lytix Biopharma is a clinical stage biotech company developing novel cancer immunotherapies, an area within cancer therapy that is aimed at activating the patient’s immune system to fight cancer. The Company’s technology is based on pioneering research in “host defense peptides” – nature’s first line of defense towards foreign pathogens. Lytix Biopharma’s lead product, LTX-315, is a first-in-class oncolytic peptide with the potential to personalize immunotherapy. LTX-315 is administered intratumorally and works by inducing lysis of intracellular organelles of tumor cells such as mitochondria.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lytix BiopharmaNorway Flag
    Country
    Country
    Norway
    Address
    Address
    Lytix Biopharma AS Hoffsveien 4, 0275 Oslo
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lytixbiopharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lytix-biopharma/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lytix Biopharma to present at the 'Frontiers in Cancer Immunotherapy 2023
    Lytix Biopharma to present at the 'Frontiers in Cancer Immunotherapy 2023

    03 May 2023

    // BUSINESSWIRE

    https://www.prnewswire.com/news-releases/lytix-biopharma-to-present-at-the-frontiers-in-cancer-immunotherapy-2023-invited-by-new-york-academy-of-sciences-301814245.html

    BUSINESSWIRE
    03 May 2023
    Share Share
    Lytix Biopharma: Invitation to presentation of fourth quarter results
    Lytix Biopharma: Invitation to presentation of fourth quarter results

    09 Feb 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lytix-biopharma-invitation-to-presentation-of-fourth-quarter-and-second-half-2022-results-thursday-16-february-301742895.html

    PR NEWSWIRE
    09 Feb 2023
    Share Share
    Lytix Biopharma appoints Stephen Worsley as Chief Business Officer
    Lytix Biopharma appoints Stephen Worsley as Chief Business Officer

    05 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lytix-biopharma-appoints-stephen-worsley-as-chief-business-officer-301617678.html

    PRNEWSWIRE
    05 Sep 2022
    Share Share
    Lytix Biopharma: Second quarter and first half of 2022 results
    Lytix Biopharma: Second quarter and first half of 2022 results

    25 Aug 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lytix-biopharma-second-quarter-and-first-half-of-2022-results-301612235.html

    PRNEWSWIRE
    25 Aug 2022
    Share Share
    Lytix Biopharma announces that an abstract on LTX-315 + Adoptive Cell Therapy
    Lytix Biopharma announces that an abstract on LTX-315 + Adoptive Cell Therapy

    15 Aug 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lytix-biopharma-as-announces-that-an-abstract-on-ltx-315-in-combination-with-adoptive-cell-therapy-is-selected-for-a-poster-presentation-at-asco-2022-301605841.html

    PRNEWSWIRE
    15 Aug 2022
    Share Share
    Lytix Biopharma AS announces that an abstract on LTX-315 + Adoptive Cell Therapy
    Lytix Biopharma AS announces that an abstract on LTX-315 + Adoptive Cell Therapy

    26 May 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lytix-biopharma-as-announces-that-an-abstract-on-ltx-315-in-combination-with-adoptive-cell-therapy-is-selected-for-a-poster-presentation-at-asco-2022-301556491.html

    PRNEWSWIRE
    26 May 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search